Literature DB >> 10830513

(10E,12Z,15Z)-9-hydroxy-10,12,15-octadecatrienoic acid methyl ester as an anti-inflammatory compound from Ehretia dicksonii.

M Dong1, Y Oda, M Hirota.   

Abstract

The methanol extract of Ehretia dicksonii provided (10E, 12Z, 15Z)-9-hydroxy-10,12,15-octadecatrienoic acid methyl ester (1) which was isolated as an anti-inflammatory compound. Compound 1 suppressed 12-Otetradecanoyl-phorbol-13-acetate (TPA)-induced inflammation on mouse ears at a dose of 500 microg (the inhibitory effect (IE) was 43%). Linolenic acid methyl ester did not inhibit this inflammation at the same dose. However, the related compounds of 1, (9Z,11E)-13hydroxy-9,11-octadecadienoic acid (5) and (9Z,llE)13-oxo-9,11-octadecadienoic acid (6), showed potent activity (IE500 microg of 63% and 79%, respectively). Compounds 1, 4 ((9Z, 12Z, 14E)-16-hydroxy-9,12,14-octadecatrienoic acid), 5 and 6 also showed inhibitory activity toward soybean lipoxygenase at a concentration of 10 microg/ml.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10830513     DOI: 10.1271/bbb.64.882

Source DB:  PubMed          Journal:  Biosci Biotechnol Biochem        ISSN: 0916-8451            Impact factor:   2.043


  3 in total

1.  Selective Production of 9R-Hydroxy-10E,12Z,15Z-Octadecatrienoic Acid from α-Linolenic Acid in Perilla Seed Oil Hydrolyzate by a Lipoxygenase from Nostoc Sp. SAG 25.82.

Authors:  Kyoung-Rok Kim; Jung-Ung An; Seon-Hwa Lee; Deok-Kun Oh
Journal:  PLoS One       Date:  2015-09-17       Impact factor: 3.240

2.  Metabolomic profile of medicinal plants with anti-RVFV activity.

Authors:  Garland Kgosi More; Jacques Vervoort; Paul Anton Steenkamp; Gerhard Prinsloo
Journal:  Heliyon       Date:  2022-02-12

3.  Phytochemical, Cytotoxic, and Antimicrobial Evaluation of Tribulus terrestris L., Typha domingensis Pers., and Ricinus communis L.: Scientific Evidences for Folkloric Uses.

Authors:  Asaad Khalid; Alanood S Algarni; Husham E Homeida; Shahnaz Sultana; Sadique A Javed; Zia Ur Rehman; Hana Abdalla; Hassan A Alhazmi; Mohammed Albratty; Ashraf N Abdalla
Journal:  Evid Based Complement Alternat Med       Date:  2022-01-27       Impact factor: 2.629

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.